[68Ga]/[177Lu]P17-087: A potential theranostic agent targeting PSMA expressing tumor

被引:0
|
作者
Kung, Hank [1 ]
Choi, Seok Rye [2 ]
Zha, Zzhihao [1 ]
Ploessl, Karl [1 ]
Alexoff, David [3 ]
机构
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Five Eleven Pharma, Philadelphia, PA USA
[3] Five Eleven Pharma Inc, Philadelphia, PA USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
O-71
引用
收藏
页码:S99 / S100
页数:2
相关论文
共 50 条
  • [41] CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [68Ga]Ga-Pentixafor/[177Lu]Lu-Pentixather
    Jacobs, Sarah M.
    Wesseling, Pieter
    de Keizer, Bart
    Tolboom, Nelleke
    Ververs, F. F. Tessa
    Krijger, Gerard C.
    Westerman, Bart A.
    Snijders, Tom J.
    Robe, Pierre A.
    van der Kolk, Anja G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (02) : 481 - 491
  • [42] 68Ga/177Lu-NeoBOMB1, a novel radiolabeled GRPR antagonist for theranostic use
    Dalm, Simone
    Bakker, Ingrid
    de Blois, Erik
    Doeswijk, Gabriela
    Konijnenberg, Mark
    Orlandi, Francesca
    Barbato, Donato
    Tedesco, Mattia
    Maina, Theodosia
    Nock, Berthold
    de Jong, Marion
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [43] Feasibility and therapeutic potential of the 68Ga/177Lu-DOTATATE theranostic pair in patients with metastatic medullary thyroid carcinoma
    Dadgar, Habibollah
    Jafari, Esmail
    Ahmadzadehfar, Hojjat
    Rekabpour, Seyed Javad
    Ravanbod, Mohammad Reza
    Kalantarhormozi, Mohammadreza
    Nabipour, Iraj
    Assadi, Majid
    [J]. ANNALES D ENDOCRINOLOGIE, 2023, 84 (01) : 45 - 51
  • [44] Initial clinical study results of 68Ga/177Lu-NYM032, a new generation of PSMA-targeting theranostic radiopharmaceuticals, in patients with metastatic prostate cancer
    He, H.
    Wang, Y.
    Mi, Y.
    Yan, C.
    Fang, P.
    Eng, W.
    Fu, H.
    Yu, C.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S180 - S181
  • [45] Value of Combined PET Imaging with [18F]FDG and [68Ga]Ga-PSMA-11 in mCRPC Patients with Worsening Disease during [177Lu]Lu-PSMA-617 RLT
    Khreish, Fadi
    Ribbat, Kalle
    Bartholomae, Mark
    Maus, Stephan
    Stemler, Tobias
    Hierlmeier, Ina
    Linxweiler, Johannes
    Schreckenberger, Mathias
    Ezziddin, Samer
    Rosar, Florian
    [J]. CANCERS, 2021, 13 (16)
  • [46] Evaluation of thresholding methods for the quantification of [68Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [177Lu]Lu-PSMA-617 radioligand therapy
    Moon Kim
    Robert Seifert
    Jana Fragemann
    David Kersting
    Jacob Murray
    Frederic Jonske
    Kelsey L. Pomykala
    Jan Egger
    Wolfgang P. Fendler
    Ken Herrmann
    Jens Kleesiek
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2196 - 2209
  • [47] Evaluation of thresholding methods for the quantification of [68Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [177Lu]Lu-PSMA-617 radioligand therapy
    Kim, Moon
    Seifert, Robert
    Fragemann, Jana
    Kersting, David
    Murray, Jacob
    Jonske, Frederic
    Pomykala, Kelsey L.
    Egger, Jan
    Fendler, Wolfgang P.
    Herrmann, Ken
    Kleesiek, Jens
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (07) : 2196 - 2209
  • [48] Association of baseline quantitative [68Ga]Ga-PSMA-11 PET imaging parameters with clinical outcomes in patients with mCRPC receiving [177Lu]Lu-PSMA-617: a VISION sub-study
    Kuo, P. H.
    Morris, M.
    Kendi, A. T.
    Rahbar, K.
    Wei, X. X.
    Fang, B.
    Armstrong, A. J.
    Hesterman, J.
    Chi, K.
    de Bono, J.
    Fizazi, K.
    Krause, B.
    Sartor, O.
    Tagawa, S. T.
    Ghebremariam, S.
    Brackman, M.
    Wong, C.
    Catafau, A. M.
    Benson, T.
    Herrmann, K.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S155 - S155
  • [49] Correlations between [68Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [177Lu]Lu-DOTA-TATE
    Bruvoll, Ragnar
    Blakkisrud, Johan
    Mikalsen, Lars Tore
    Connelly, James
    Stokke, Caroline
    [J]. CANCERS, 2023, 15 (04)
  • [50] The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors
    Simsek, Duygu Has
    Guzel, Yunus
    Denizmen, Dilara
    Sanli, Yasemin
    Buyukkaya, Fikret
    Kovan, Bilal
    Komek, Halil
    Isik, Emine Goknur
    Ozkan, Zeynep Gozde
    Kuyumcu, Serkan
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (03) : 828 - 840